Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$436K Hold
1,380
0.16% 67
2024
Q2
$463K Buy
1,380
+1
+0.1% +$294 0.17% 63
2024
Q1
$377K Sell
1,379
-44
-3% -$12.9K 0.15% 72
2023
Q4
$446K Hold
1,423
0.18% 58
2023
Q3
$399K Sell
1,423
-183
-11% -$45.7K 0.19% 50
2023
Q2
$357K Hold
1,606
0.16% 63
2023
Q1
$385K Sell
1,606
-38
-2% -$9.33K 0.17% 56
2022
Q4
$401K Buy
1,644
+1
+0.1% +$268 0.18% 60
2022
Q3
$381K Sell
1,643
-47
-3% -$11.4K 0.19% 56
2022
Q2
$416K Sell
1,690
-88
-5% -$21.6K 0.2% 56
2022
Q1
$445K Buy
1,778
+2
+0.1% +$460 0.2% 66
2021
Q4
$418K Buy
1,776
+2
+0.1% +$422 0.18% 77
2021
Q3
$370K Buy
+1,774
New +$408K 0.16% 83

Other funds holding AMGN

TNF's AMGN Position: Q3 2024 in Review

TNF held its Amgen (AMGN) position steady in Q3 2024 at 1,380 shares worth $436K. The position accounts for 0.16% of the portfolio, ranked #67.

TNF first reported a position in AMGN in Q3 2021 and has held it in 13 quarters since. The position peaked at $463K in Q2 2024. 2,823 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.

  • TNF held 1,380 shares of Amgen worth $436K as of Q3 2024.
  • TNF left its Amgen share count unchanged in Q3 2024.
  • Amgen made up 0.16% of TNF's portfolio in Q3 2024, its #67 holding.
  • TNF first reported a position in Amgen in Q3 2021 and has held it in 13 quarters since.
  • TNF's Amgen position peaked at $463K in Q2 2024.
  • 2,823 funds tracked by Wall St. Rank held Amgen as of Q3 2024.

Based on TNF's 13F filing for Q3 2024, filed 25 Oct 2024.